ResMed Collaborates With Rival To Raise Awareness Of Sleep Disorders
This article was originally published in The Gray Sheet
Executive Summary
ResMed is collaborating with main competitor Respironics to promote sleep disorder therapy for a variety of chronic conditions
You may also be interested in...
People In Brief
FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
People In Brief
FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
Sleep Test Coverage Policy, ResMed/Respironics Talks Could Awaken Market
ResMed plans to work with Respironics to generate data that will raise the public and professional profile of sleep-disordered breathing (SDB) devices, which have an estimated $600 mil. U.S. market potential